Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

July 31, 2007

Conditions
Major Depressive Disorder
Interventions
DRUG

Quetiapine fumarate

Trial Locations (56)

Unknown

Research Site, Phoenix

Research Site, El Centro

Research Site, Irvine

Research Site, Oceanside

Research Site, San Diego

Research Site, Pueblo

Research Site, Coral Springs

Research Site, DeLand

Research Site, Gainsville

Research Site, Hialeah

Research Site, Jacksonville

Research Site, Miami

Research Site, Orlando

Research Site, West Palm Beach

Research Site, Atlanta

Research Site, Roswell

Research Site, Hoffman Estates

Research Site, Naperville

Research Site, Oak Brook

Research Site, Indianapolis

Research Site, Lafayette

Research Site, Valparaiso

Research Site, Prairie Village

Research Site, Wichita

Research Site, Shreveport

Research SIte, Glen Burnie

Research Site, Braintree

Research Site, Springfield

Research Site, Clinton Township

Research Site, Kalamazoo

Research Site, Royal Oak

Research Site, Saint Charles

Research Site, St Louis

Research Site, Cherry Hill

Research Site, Clementon

Research Site, Cedarhurst

Research Site, New York

Research Site, Olean

Research Site, Rochester

Research Site, Staten Island

Research Site, Beechwood

Research Site, Toledo

Research Site, Norman

Research Site, Oklahoma City

Research Site, Philadelphia

Research Site, Lincoln

Research Site, Columbia

Research Site, Memphis

Research Site, Friendswood

Research Site, Houston

Research Site, San Antonio

Research SIte, Wichita Falls

Research Site, Salt Lake City

Research Site, Arlington

Research Site, Richmond

Research Site, Bellevue

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY